NP / PA
Nesemeyer, Stephanie
Nesemeyer, Stephanie was paid $229K by Medicaid between Jan 2018 and Dec 2024, across 8 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 76% of everything it billed.
33Billing provider infoNESEMEYER, STEPHANIE
MONROE, WI 53566
MONROE, WI 53566
33aNPI1962701318assigned 03/24/2011
33bProvider typeFamily Nurse Practitioner
28Total paid$229K
24GClaims5,758
24DCodes billed8
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Wisconsin
Rank by total paid#4 of 180
Median peer was paid$2K
This provider vs. median100×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 387 | $10K | |
| 2019 | 855 | $29K | |
| 2020 | 881 | $32K | |
| 2021 | 786 | $39K | |
| 2022 | 902 | $40K | |
| 2023 | 1,069 | $38K | |
| 2024incomplete | 878 | $42K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 76% | 3,801 | 3,568 | $174K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 972 | 954 | $23K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.7% | 249 | 130 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.4% | 500 | 479 | $8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 86 | 86 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 14 | 14 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 24 | 24 | $2K |
| 87081 | <1% | 112 | 110 | $649.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.